August 20, 2026

How Should a Startup Structure Bridge Financing if a Major Customer Contract is Expected to be The Next Financing Catalyst?

IRC Partners Research
In This Article
Startup bridge financing structured around an expected major customer contract and next funding round
August 20, 2026

How Should a Startup Structure Bridge Financing if a Major Customer Contract is Expected to be The Next Financing Catalyst?

IRC Partners Research

A startup should structure a contract-catalyst bridge as a milestone-linked convertible note with two or three tranches, a maturity date set 60 to 90 days beyond the expected contract execution date, and lender protections that trigger if the contract does not close on schedule. The bridge is designed to fund operations through the signing window and convert automatically once the contract closes and a priced round launches. This structure is different from a standard bridge because the repayment or conversion event is tied to a commercial outcome. For a broader overview of how pay-to-play mechanics interact with bridge financing, see the full guide to structuring pay-to-play bridge financing when preferred investors decline to participate.

The challenge is timing. A pending customer contract is valuable but uncertain. It has not closed yet. Investors who fund the bridge are taking on contract execution risk in addition to normal business risk. If the contract slips or falls apart, the bridge note matures without a clear path to repayment. That risk must be priced and documented before the first dollar moves. Founders who treat a contract-catalyst bridge like a standard rolling bridge often find that lenders pull back or demand punitive terms when the contract timeline shifts. Getting the sequencing right before you launch the bridge is one of the core decisions covered in raise strategy sequencing for founders.

Why a Pending Contract Creates a Different Kind of Bridge Problem

A standard bridge note buys time. It keeps the lights on while a priced round closes. The maturity date is set to a fixed calendar window, and investors accept that the company will raise equity before the note comes due.

A contract-catalyst bridge is structurally different. The priced round is not happening until the contract signs. That means the bridge note's repayment or conversion event depends on a third party: the customer. The customer's legal team, procurement process, and internal approvals are all outside the founder's control.

This creates three specific problems that standard bridge documentation does not address:

  • Uncertain maturity timing. A fixed maturity date may come before the contract signs. If the note matures before conversion is possible, the company is in default without having done anything wrong.
  • Lender exposure to commercial risk. Bridge investors are now underwriting the customer relationship, not just the startup's runway. They need visibility into the contract's status, probability of close, and any conditions precedent.
  • Round sequencing pressure. The priced round cannot launch until the contract is signed and the revenue is real. Investors who fund the bridge need to understand that the equity round timeline depends on the contract closing, nothing the founder controls unilaterally.

As academic analysis of bridge note structures in venture finance notes, bridge notes carry both priority over equity holders and a formal maturity date, which means a maturity event without a clear conversion path puts the company in a difficult creditor position. Founders who do not account for this in the original term sheet often face rushed renegotiations at the worst possible moment.

The Framework: How to Structure a Contract-Catalyst Bridge

The goal is a note structure that gives lenders adequate protection if the contract slips, gives the company enough runway to reach signing, and converts cleanly once the catalyst event occurs. The framework has four components.

1. Milestone-Based Tranches

Fund the bridge in two or three tranches rather than a single draw. The first tranche covers immediate operating needs. Subsequent tranches release upon defined milestones tied to contract progress, such as a signed term sheet with the customer, completion of the customer's legal review, or confirmation of a specific contract execution date.

This approach reduces lender risk on each draw. If the contract falls apart between tranches, the lender's exposure is limited to what has already been funded. For a detailed breakdown of how to define and document tranche release conditions, see the IRC guide on structuring milestone-based tranches in a bridge financing agreement.

The October 2025 updates to the National Venture Capital Association's model legal documents formally introduced milestone-based tranched financing language into the Stock Purchase Agreement framework, confirming that this structure is now a recognized market practice, not a bespoke workaround.

2. Maturity Date Tied to Contract Execution

Set the maturity date 60 to 90 days after the expected contract execution date. This buffer accounts for normal contract delays without forcing the company into default. The term sheet should define the expected execution date explicitly and allow for one extension of 30 to 60 days if the company provides written evidence that the contract is still on track.

Avoid setting the maturity date to a fixed calendar date with no reference to the contract timeline. That structure puts the company at risk of a technical default caused entirely by the customer's internal delays.

3. Lender Protections for a Future-Event Catalyst

When the conversion event is a future commercial outcome, lenders need contractual protections that do not exist in a standard bridge note. These typically include:

  • Contract status reporting. A monthly or bi-weekly written update to note holders on the contract's status, including any material changes to the expected signing date.
  • Material adverse change trigger. If the customer formally withdraws, the contract is terminated, or the company receives written notice that the deal is unlikely to close, the note accelerates to a shorter maturity window, typically 30 to 60 days.
  • Conversion discount tied to delay. If the contract closes later than the expected date, the note holder receives an additional conversion discount, typically 2 to 5 percentage points per month of delay, up to a defined cap. This compensates lenders for carrying additional time risk.

For guidance on documenting what happens when bridge investors do not fulfill their obligations under a multi-close structure, the IRC article on investor default remedies in multi-close bridge financings covers the documentation requirements in detail.

4. Conversion Mechanics

The note should convert automatically at the closing of the priced equity round that follows the contract signing. The conversion terms should be agreed in the original note, including the valuation cap, the discount rate, and whether the conversion is into the same class as the priced round investors or into a separate series. Founders who carry unresolved bridge notes into a priced round without modeling the conversion math first often discover dilution problems at the worst possible moment - the IRC guide on how accrued interest compounds convertible note dilution before a priced round covers the mechanics in detail.

Agree on these terms before the bridge closes. Renegotiating conversion terms after the contract signs puts the company in a weak position at exactly the moment when the priced round investors are watching.

{{main-cta}}

What Proper Structuring Looks Like in Practice

A B2B software company was in late-stage negotiations with a large enterprise customer. The contract represented a meaningful revenue jump and was expected to serve as the anchor for a Series B raise. The company needed capital to fund its implementation team and sales pipeline through the signing window, which was projected to take three to four months.

The company's existing investors were willing to participate in a bridge but wanted protection against contract slippage. New outside investors were interested but declined to commit on a single-draw note with a fixed maturity date that did not account for the customer's procurement timeline.

The solution was a two-tranche convertible note. The first tranche funded immediately and covered four months of operating costs. The second tranche was tied to a specific milestone: delivery of a signed letter of intent from the customer. The note's maturity date was set 75 days after the customer's internally communicated target execution date, with a 45-day extension available upon written confirmation from the company's legal counsel that the contract was still in active negotiation.

The note also included a material adverse change trigger. If the customer formally withdrew, the maturity window would shorten to 45 days, giving the company time to pursue alternative capital while limiting lender exposure.

The customer signed the contract on schedule. The second tranche released. The Series B launched within 60 days of contract execution, and the bridge converted at the agreed terms with no renegotiation. The structure worked because every contingency was documented before the first dollar was drawn, not after the contract signed.

Key takeaway: The documentation work happens before the bridge closes. Founders who wait until the contract signs to negotiate conversion terms lose leverage at the exact moment investors have the most of it.

What Founders Should Do Before the Contract Signs

The window between a verbal commitment from the customer and a signed contract is the right time to structure the bridge. Once the contract signs, the leverage shifts. Investors know the risk has cleared, and they will negotiate conversion terms accordingly.

Three steps to take during that window:

  1. Get the customer's expected timeline in writing. Even an informal email confirming the target execution date gives you a document to anchor the bridge note's maturity date. Without it, the maturity date is a guess.
  2. Draft the bridge term sheet before approaching investors. A well-drafted term sheet signals that you understand the structure. It also gives investors something to react to rather than negotiate from scratch.
  3. Engage capital advisory support early. A contract-catalyst bridge involves lender protections, milestone definitions, and conversion mechanics that interact with your existing cap table and investor rights. Getting those terms right requires someone who has structured this type of instrument before.

IRC Partners works with founders raising $5M to $250M who are navigating bridge structures tied to commercial milestones. If a major customer contract is on the horizon and you need capital to reach it, the time to structure the bridge is before the contract closes, not after.

Frequently Asked Questions

How long should the maturity date on a contract-catalyst bridge note extend beyond the expected contract signing date?

The standard buffer is 60 to 90 days beyond the expected contract execution date. This accounts for typical procurement delays without giving the company an indefinite runway. The term sheet should also allow for one extension of 30 to 60 days if the company can provide written evidence that the contract is still in active negotiation and that no material adverse change has occurred.

What happens to the bridge note if the customer contract falls through entirely?

If the contract is formally terminated or the customer withdraws, the note typically accelerates to a shortened maturity window, often 30 to 60 days, under a material adverse change trigger. The company then needs to either repay the note, raise alternative capital, or renegotiate the maturity terms with note holders. This is why the MAC trigger and its consequences must be agreed in the original term sheet, before any funds are drawn.

Should the bridge be structured as a convertible note or a SAFE when the catalyst is a customer contract?

A convertible note is the standard instrument for this structure. It has a formal maturity date, accrues interest, and gives the holder priority over equity holders in a liquidation event. A SAFE has no maturity date and no interest accrual, which removes the lender's ability to enforce repayment if the contract does not close. When lenders are taking on commercial risk tied to a third-party contract, they typically require the enforcement rights that come with a convertible note.

How do you define the milestones for tranche releases when the catalyst is a commercial contract?

Milestones should be objective and verifiable. Good milestones for a contract-catalyst bridge include a signed letter of intent from the customer, completion of the customer's legal review, or a written confirmation of the target execution date from the customer's procurement team. Milestones tied to internal company metrics, such as revenue targets or headcount, are less useful here because they do not directly measure progress toward the contract signing.

Can existing preferred investors participate in a contract-catalyst bridge, and does it affect their pay-to-play obligations?

Existing preferred investors can participate. Whether their participation satisfies or triggers pay-to-play obligations depends on the language in the existing investor rights agreement and the terms of the bridge round itself. A bridge structured outside of a formal pay-to-play mechanism may not count as a qualifying round under the existing documents. Founders should have counsel review the existing investor rights agreement before structuring the bridge to confirm whether participation creates or satisfies any pay-to-play obligations.

What conversion discount is reasonable for a bridge note where the catalyst is a future contract rather than a priced round already in progress?

The standard conversion discount for a bridge note is 15 to 20 percent. When the catalyst is a future commercial event rather than an in-progress round, lenders are taking on additional uncertainty. A discount of 20 to 25 percent is more common in this structure, sometimes paired with a delay penalty of 2 to 5 percentage points per month if the contract closes later than the agreed target date. The valuation cap and discount work together; founders should model both before agreeing to terms.

What board approvals are typically required before a startup can close a contract-catalyst bridge round?

Board approval is required in most cases. The board needs to authorize the issuance of the convertible notes, approve the material terms including the maturity date, interest rate, conversion discount, and valuation cap, and confirm that the bridge does not violate any existing investor rights or consent requirements. If the bridge includes a pay-to-play mechanism or modifies existing preferred stock rights, additional stockholder consent may be required. For a detailed breakdown of what the board should review before approving an insider-led bridge, see the IRC guide on board review requirements before approving an insider-led bridge financing round.

Continue reading this series:

IRC Partners advises operators raising $5M to $250M of institutional capital on structure, positioning, and round architecture. We take seven strategic partners per quarter. No placement agent model. No success-only theater. Capital is raised on the strength of how the deal is built. If you want your current raise reviewed before it reaches the market and silently fails, apply here

Need guidance on your capital raise?

IRC Partners advises operators raising $5M to $250M of institutional capital. The Capital Raise Pre-Flight runs your deal through critical investor screening gates before any of them see it.
Book Your Pre-Flight Consult
Share this post:
Related Reading

Disclosure

The content published on this website is provided by IRC Partners (InvestorReadyCapital.com) for informational and educational purposes only. Nothing contained herein constitutes financial, investment, legal, or tax advice, nor should any content be construed as a solicitation, recommendation, or offer to buy or sell any security or investment product of any kind.

Nothing on this site constitutes an offer to sell, or a solicitation of an offer to purchase, any security under the Securities Act of 1933, as amended, or any applicable state securities laws. Any offering of securities is made only by means of a formal private placement memorandum or other authorized offering documents delivered to qualified investors.

IRC Partners is a capital advisory firm. IRC Partners is not a registered investment adviser under the Investment Advisers Act of 1940 and does not provide investment advice as defined thereunder.

Certain statements in this article may constitute forward-looking statements, including statements regarding market conditions, capital availability, investor demand, and transaction outcomes. Such statements reflect current assumptions and expectations only. Actual results may differ materially due to market conditions, regulatory developments, company-specific factors, and other variables. IRC Partners makes no representation that any outcome, return, or result described herein will be achieved.

References to prior mandates, transaction volume, network credentials, or capital raised are provided for illustrative purposes only and do not constitute a guarantee or prediction of future results. Past performance is not indicative of future outcomes. Individual results will vary. Network credentials and transaction statistics referenced on this site reflect the aggregate experience of IRC Partners' principals and affiliated advisors and are not a representation of assets managed or transactions closed solely by IRC Partners.

Certain data, statistics, and information presented in this article have been obtained from third-party sources. IRC Partners has not independently verified such information and expressly disclaims responsibility for its accuracy, completeness, or timeliness. Readers should independently verify any third-party data before relying on it.

Readers are strongly encouraged to consult qualified legal, financial, and tax professionals before making any investment, capital raising, or business decision.

Schedule A Meeting

You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.

We onboard a maximum of seven
 new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.